BNTC Benitec Biopharma Inc.: institutional ownership and insider trading
91 funds reported holding $490M of Benitec Biopharma Inc. in their latest 13F filings; in Q2 2026 funds net bought $14.1M, with 10 new positions and 10 funds selling out; over the last 12 months insiders bought $22.4M and sold $0 on the open market.
BNTC revenue and earnings
- Quarter ended Mar 31, 2026: revenue $0, net income −$11.9M, EPS -0.24
- Quarter ended Dec 31, 2025: revenue $0, net income −$11.8M, EPS -0.26
- Quarter ended Sep 30, 2025: revenue $0, net income −$8.97M, EPS -0.22
- Quarter ended Jun 30, 2025: revenue n/a, net income −$8.81M, EPS -0.21
Famous investors holding BNTC
- Izzy Englander (Millennium Management): $12.3M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $1.09M, 0.0% of the portfolio
Largest institutional holders of BNTC
- SUVRETTA CAPITAL MANAGEMENT, LLC — $155M
- Jupiter Topco LLC — $33.1M
- FRANKLIN RESOURCES INC (BEN) — $32.3M
- JANUS HENDERSON GROUP PLC (JHG) — $30.7M
- ADAGE CAPITAL PARTNERS GP, L.L.C. — $28.4M
- RA CAPITAL MANAGEMENT, L.P. — $24.8M
- Nantahala Capital Management, LLC — $19.9M
- BlackRock, Inc. (BLK) — $18.8M
- VANGUARD GROUP INC — $15.8M
- Simplify Asset Management Inc. — $13.5M
Recent BNTC insider trades
- Dec 29, 2025: Suvretta Capital Management, Llc bought 144,223 shares ($1.90M)
- Dec 22, 2025: Suvretta Capital Management, Llc bought 46,141 shares ($539K)
- Nov 7, 2025: Suvretta Capital Management, Llc bought 1,481,481 shares ($20.0M)
- Mar 31, 2025: Suvretta Capital Management, Llc bought 16,497 shares ($212K)
5%+ owners
- SUVRETTA CAPITAL MANAGEMENT, LLC: 44.1% (Schedule 13D/A, filed Nov 10, 2025)
- Franklin Resources, Inc.: 10.6% (Schedule 13G/A, filed Jan 29, 2026)
- JANUS HENDERSON GROUP PLC: 10.0% (Schedule 13G/A, filed Dec 8, 2025)
- RA Capital Management, L.P.: 5.5% (Schedule 13G, filed Dec 3, 2025)
Who owns the most BNTC stock?
The largest institutional holders of Benitec Biopharma Inc. in the latest 13F filings are SUVRETTA CAPITAL MANAGEMENT, LLC ($155M), Jupiter Topco LLC ($33.1M), FRANKLIN RESOURCES INC (BEN) ($32.3M).
Are insiders buying or selling BNTC?
Over the last 12 months insiders bought $22.4M and sold $0 of Benitec Biopharma Inc. stock on the open market (SEC Form 4).
Which famous investors own BNTC?
Izzy Englander, Ken Griffin.
What was BNTC's revenue last quarter?
Benitec Biopharma Inc. reported revenue of $0 for the quarter ended March 31, 2026, with net income of −$11.9M.
Which ETFs hold BNTC?
4 ETFs and mutual funds hold it among their top 100 positions, including PINK, FBDIX, GNOM, IBRN.